Advertisement

Key CDC panel recommends Pfizer-BioNTech vaccine for those 16 and over

Key CDC panel recommends Pfizer-BioNTech vaccine for those 16 and over
The CDC recommendation comes a week after the Pfizer/BioNTech vaccine won the full approval of the Food and Drug Administration. File Photo by Kevin Dietsch/UPI | License Photo

Aug. 30 (UPI) -- A Centers for Disease Control and Prevention advisory panel on Monday voted to recommend the use of the Pfizer and BioNTech COVID-19 vaccine for all Americans ages 16 and older.

The CDC's Advisory Committee on Immunization Practices unanimously approved a measure urging agency director Dr. Rochelle Walensky to recommend the vaccine for any patient in the age group.

Advertisement

The 14-0 vote came a week after the U.S. Food and Drug Administration granted full approval for the Pfizer-BioNTech vaccine -- a step hailed by U.S. officials as hopefully leading to increased vaccinations and more mandates from businesses and other entities.

The ACIP panel had previously voted in favor of an interim recommendation before the vaccine was fully approved.

RELATED Immune response to COVID-19 vaccines declines after two months, study finds

While its Monday vote was essentially a formality, the panel's endorsement further reinforced the scientific backing of the Pfizer-BioNTech vaccine's safety at a time when coronavirus infections continued to surge in the United States.

Some authorities have said the Delta variant has driven a resurgence of cases in the United States and other countries, in part, due to those who have refused to be vaccinated.

Advertisement

The seven-day moving average of new daily new cases rose 2.8% to just over 142,000 last week, according to CDC data -- 1,118% higher than the seven-day average recorded on June 18.

RELATED CDC: Unvaccinated teacher spread COVID-19 to 12 students

As of Thursday, about 203 million people, or 61% of the total U.S. population, had received at least one dose of COVID-19 vaccine, while about 52% had been fully vaccinated. The seven-day average number of administered vaccine doses was 877,756 last week, a 6.6% increase from the previous week.

Pfizer's vaccine was the first to be distributed in the United States and was shown to be better than 94% effective against the virus that causes COVID-19. Scientists are still testing the vaccine, as well as others from Moderna and Johnson & Johnson, to see how well it guards against mutated strains like the Delta variant.

A year in pandemic: How COVID-19 changed the world

National Institutes of Health official Dr. Anthony Fauci (C) speaks about the coronavirus during a press briefing at the White House in Washington, D.C. Health and Human Services Secretary Alexander Azar (L) announced that the United States is declaring the virus a public health emergency and issued a federal quarantine order of 14 days for 195 Americans. Photo by Leigh Vogel/UPI | License Photo

RELATED Texas governor reissues ban on COVID-19 vaccine mandates

Latest Headlines

Advertisement
Advertisement

Follow Us

Advertisement